BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PoolParty Semantic Suite - ECPv6.5.1.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.poolparty.biz
X-WR-CALDESC:Events for PoolParty Semantic Suite
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20231205T160000
DTEND;TZID=Europe/Vienna:20231205T170000
DTSTAMP:20260510T201930
CREATED:20230810T115828Z
LAST-MODIFIED:20250326T142602Z
UID:156617-1701792000-1701795600@www.poolparty.biz
SUMMARY:Webinar: Making BioPharma AI-Ready
DESCRIPTION:ON-DEMAND WEBINAR \n			\n				\n				\n				\n				\n				MAKING BIOPHARMAAI-READY\n  \nCreating Scientific Data for Analytical Development\n			\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n			\n			\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n					\n					\n						Speakers\n						Lindsey Weed\, Ph.D.\, Scientific Business Analyst\, TetraScience \nGordon Hayden\, Chief Growth Officer\, Semantic Web Company \n					\n				\n			\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n					\n					\n						Date\n						December 5\, 2023 \n					\n				\n			\n			\n				\n				\n				\n				\n				\n			\n				\n				\n				\n				\n			\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				Heterogeneous Data Formats Prohibit Advanced Analytics and AI  \nThe pharmaceutical industry is experiencing a surge in scientific data due to the growing complexity of new therapeutic modalities and the urgency to bring improved therapeutics to market more efficiently. However\, this valuable scientific data is often trapped in on-premise instrument control and acquisition software\, compounded by the challenge of dealing with diverse vendor-specific data formats\, thus inhibiting the potential of AI. \nIs Engineered Scientific Data the Force Multiplier for AI? \nIn this webinar\, we will explore a use case involving a leading pharmaceutical company that aims to provide its scientists and engineers with analytics and AI-ready data across multiple laboratories\, departments\, and facilities. \nBy making this data available\, scientists can leverage prior work to inform their actions and improve scientific outcomes. Moreover\, they can identify and accelerate the most promising scientific strategies \, leading to substantial time and cost savings. \nThis webinar will address several crucial aspects of maximizing the value of scientific data in the biopharmaceutical industry\, including: \n\nCentralizing and harmonizing scientific data\nImproving collaboration and data sharing\nLeveraging Semantic AI in biopharma\nManaging diverse taxonomies efficiently\nAutomating data preparation and engineering\n\nDon’t miss this opportunity to discover how your organization can maximize the value of your data and accelerate scientific advancements through AI. \n			\n				\n				\n				\n				\n				\n				\n			\n			\n				\n				\n				\n				\n			\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				Speakers\n			\n			\n				\n				\n				\n				\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n					Lindsey Weed\, Ph.D.\n					Scientific Business Analyst at TetraScience \n					Lindsey is a member of the scientific applications product team at TetraScience. She leverages her past experience as a bench scientist at both biopharmaceutical and biotechnology companies to understand how daily data management challenges impact scientific insight and action so that she can create productionized\, end-to-end data workflows for scientific use cases. Lindsey received her Ph.D. in Molecular and Cellular Biology from the University of Pennsylvania with a concentration in viral-mediated gene therapies. She is passionate about the benefits of data sharing and open science. \n					XLinkedIn\n				\n			\n			\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n				\n					Gordon Hayden\n					Chief Growth Officer at Semantic Web Company \n					Gordon Hayden is Chief Growth Officer at Semantic Web Company (SWC)\, the provider and developer of the PoolParty Semantic Platform. With headquarters in Vienna\, Austria\, but operating globally\, SWC has worked with over 200 commercial\, government\, and non-profit organizations to deliver AI and semantic search solutions\, knowledge platforms\, content hubs\, and related data modeling and integration services. SWC was named to KMWorld’s prestigious list of “100 Companies that Matter in Knowledge Management” from 2016 to 2022 and has been named multiple times in Gartner’s Magic Quadrant for Metadata Management Solutions and as a Sample Vendor in their Hype Cycle for Natural Language Technologies. \nIn his current role\, Gordon provides a platform for growth in general for SWC but specifically via Software Partners who require an integration with PoolParty to Semantically enrich their solutions. This covers new additions with an Application Development Framework for ease of use for integrations and a Recommender option. \nHe is originally from South Africa where he worked at Hewlett Packard and CA Technologies in various roles before moving to Vienna\, Austria 5 years ago. He holds an MBA degree from the University of Wales. \n					XLinkedIn
URL:https://www.poolparty.biz/events/making-biopharma-ai-ready
LOCATION:RECORDING AVAILABLE
CATEGORIES:On-demand Webinars
ATTACH;FMTTYPE=image/png:https://www.poolparty.biz/wp-content/uploads/2023/08/Making-Big-Pharma-AI-Ready_featured-image.png
END:VEVENT
END:VCALENDAR